FDA has released a guidance document that provides step-by-step instructions to manufacturers of retail food products marketed in the U.S. on how they may convert the previous units of measure for certain nutrients on the Nutrition and Supplement Facts Label to the new units in the updated Nutrition Facts label.

New chapters and sections of the Fish and Fishery Products Hazards and Controls Guidance, including the updated 21 CFR Part 123—Fish and Fishery Products, were updated by the FDA in August.

Bad news first: If you make pet food, have an older facility and have been putting off examining your operation in light of FSMA, rushing to comply with the new food safety rules for animal foods is probably proving to be a challenge.

When finalized, this draft guidance will make the sprout seed industry aware of the FDA’s serious concern with the continuing outbreaks of foodborne illness associated with the consumption of raw and lightly cooked sprouts and provide their recommendations to firms throughout the production chain of seed for sprouting.

FDA has issued a final guidance to provide clarity on the labeling of added sugars for single-ingredient packages or containers of pure honey, maple syrup and other single ingredient sugars and syrups as a result of a requirement contained in the Agriculture Improvement Act of 2018 (Pub. L. 115-334), known as the Farm Bill.

The FDA recently held a hearing designed to include information and views related to the safety of cannabis edibles and beverages—with a strong emphasis on cannabidiol (CBD) ingredients—as well as to solicit input relevant to the agency's regulatory strategy for existing products.

FDA intends to exercise this enforcement discretion to provide industry with greater flexibility when labeling food products, including those formulated to reduce sodium content.

Many processors have grown more sophisticated at compiling information and presenting it when inspectors ask for proof that a facility's food safety management system is working. But no matter the companies’ size or record management methods, they likely experience some of the common deficiencies that experts see.

In a new draft guidance, "Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C," there are recommendations in three key areas: training, recordkeeping and procedures.

The FDA held a public hearing on May 31 to solicit oral presentations and comments in order to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of products containing cannabis or cannabis-derived products.